Key Highlights:
- Arboreal Bioinnovations has raised ₹230 crore in a Series A co-led by EAAA Alternatives and Omnivore, with continued backing from Rainmatter. The company will use the funds to expand manufacturing, R&D and commercialisation.
- Building on its ingredient technology platform, Arboreal develops next-gen proteins, cocoa ingredients, zero-calorie sweeteners and functional fibres. Its innovations have supported 300+ product launches across 1,100+ brands in 18 months.
- With growth more than doubling year-on-year, Arboreal now aims to deepen its science, manufacturing and talent capabilities, while scaling India-developed ingredient technologies for global food, beverage and nutraceutical markets.
Implications:
The ₹230 crore Series A gives Arboreal the capital to scale its ingredient technology platform, expand manufacturing and accelerate R&D and commercialisation. The funding could strengthen its position in functional food and nutraceutical ingredients while helping scale its portfolio across domestic and global markets.
Source: ExpressPharma
